TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Angarns Bio AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,611
|
2,076
|
1,774 |
| Financial expenses |
10
|
22
|
15 |
| Earnings before taxes |
1,110
|
1,876
|
1,622 |
| EBITDA |
1,139
|
1,947
|
1,696 |
| Total assets |
13,274
|
13,369
|
12,545 |
| Current assets |
1,592
|
1,754
|
833 |
| Current liabilities |
180
|
535
|
1,095 |
| Equity capital |
13,094
|
12,834
|
11,355 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
98.6%
|
96.0%
|
90.5% |
| Turnover per employee |
1,611
|
2,076
|
1,774 |
| Profit as a percentage of turnover |
68.9%
|
90.4%
|
91.4% |
| Return on assets (ROA) |
8.4%
|
14.2%
|
13.0% |
| Current ratio |
884.4%
|
327.9%
|
76.1% |
| Return on equity (ROE) |
8.5%
|
14.6%
|
14.3% |
| Change turnover |
-396
|
293
|
291 |
| Change turnover % |
-20%
|
16%
|
20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.